Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Genetic history maps centuries of European migration

Research

Genetics researchers at the University of Oxford have used DNA to map the history of population movements in and around Europe. The technique may help historians to understand more about how over nearly three thousand years people across the continent have migrated, mingled and multiplied. Their results are published in the journal Current Biology.

Studying 500,000 genetic markers in 2000 samples, the international team including the Department of Zoology and the Wellcome Trust Centre for Human Genetics and led by Prof Cristian Capelli, looked at how genes had been exchanged between 1000BCE and 1950. While half the samples were from within Western Eurasia (Europe, the Caucasus and areas of the Middle East), half were from other areas of the world, enabling the researchers to trace not only which groups moved around Europe, but also which groups migrated to the continent.

Read more (University of Oxford website)

Further information (Capelli Group website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

NCITA Publishes Comment Article in the British Journal of Cancer

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.